These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


488 related items for PubMed ID: 19520548

  • 21. Intravenous levetiracetam terminates refractory focal status epilepticus.
    Abend NS, Florance N, Finkel RS, Licht DJ, Dlugos DJ.
    Neurocrit Care; 2009; 10(1):83-6. PubMed ID: 18181032
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The use of levetiracetam in a child with nonconvulsive status epilepticus.
    Alehan F, Ozcay F, Haberal M.
    J Child Neurol; 2008 Mar; 23(3):331-3. PubMed ID: 18192652
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Intravenous levetiracetam treatment in status epilepticus: A prospective study.
    Atmaca MM, Orhan EK, Bebek N, Gurses C.
    Epilepsy Res; 2015 Aug; 114():13-22. PubMed ID: 26088881
    [Abstract] [Full Text] [Related]

  • 29. Successful treatment for refractory convulsive status epilepticus by non-parenteral lacosamide.
    Tilz C, Resch R, Hofer T, Eggers C.
    Epilepsia; 2010 Feb; 51(2):316-7. PubMed ID: 19674050
    [Abstract] [Full Text] [Related]

  • 30. Intravenous levetiracetam in critically ill children with status epilepticus or acute repetitive seizures.
    Abend NS, Monk HM, Licht DJ, Dlugos DJ.
    Pediatr Crit Care Med; 2009 Jul; 10(4):505-10. PubMed ID: 19325512
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Intravenous levetiracetam in clinical practice--Results from an independent registry.
    Lang N, Esser W, Evers S, Kellinghaus C, Nguento A, Schlegel U, Gaida B, Gburek-Augustat J, Altenmüller DM, Burghaus L, Hoffmann F, Fiedler B, Bast T, Rehfeld T, Happe S, Seitz RJ, Boor R, Stephani U.
    Seizure; 2015 Jul; 29():109-13. PubMed ID: 26076852
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Effectiveness of intravenous levetiracetam as an adjunctive treatment in pediatric refractory status epilepticus.
    Kim JS, Lee JH, Ryu HW, Lim BC, Hwang H, Chae JH, Choi J, Kim KJ, Hwang YS, Kim H.
    Pediatr Emerg Care; 2014 Aug; 30(8):525-8. PubMed ID: 25062293
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Use of intravenous levetiracetam for management of acute seizures in neonates.
    Khan O, Chang E, Cipriani C, Wright C, Crisp E, Kirmani B.
    Pediatr Neurol; 2011 Apr; 44(4):265-9. PubMed ID: 21397167
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. A Comparison of Intravenous Levetiracetam and Valproate for the Treatment of Refractory Status Epilepticus in Children.
    İşgüder R, Güzel O, Ceylan G, Yılmaz Ü, Ağın H.
    J Child Neurol; 2016 Aug; 31(9):1120-6. PubMed ID: 27080042
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 25.